Skip to main content

Table 1 MDP 301 Uganda: eligibility criteria

From: Uptake of hormonal contraceptives and correlates of uptake in a phase III clinical trial in rural South Western Uganda

Eligible

Ineligible

• Sexually active

• 16 years old or above

• HIV-negative at screening

• Willing to undergo regular HIV testing and receive the result before randomisation

• Willing to undergo regular speculum examinations and genital infection screens

• Willing to have regular urine pregnancy tests

• Willing to use study gel as instructed

• Willing to receive health education about condoms

• Willing and able to give informed consent

• Unable or unwilling to provide a reliable method of contact for the field team

• Likely to move permanently out of the area within the next year

• Likely to have sex more than 14 times a week on a regular basis during the course of follow-up

• Using spermicides regularly

• Pregnant or within 6 weeks postpartum at enrolment

• Had a severe clinical or laboratory abnormality

• Requiring referral for assessment of a clinically suspicious cervical lesion

• Had treatment to the cervix, or to the womb through the cervix, within 30 days of enrolment

• Had known latex allergy

• Participating, or having participated within 30 days of enrolment, in a clinical trial of an unlicensed product, microbicide, barrier method or any other intervention likely to impact on the outcome of this trial

Considered unlikely to be able to comply with the protocol